Transdermal Skin Patches Market Size And Forecast Report 2024-2032

Transdermal Skin Patches Market

Renub Research projects the global transdermal skin patch market to reach US$ 9.90 billion by 2030. As a result, in 2023, Transdermal Skin Patches Market  the global market for transdermal skin patches was estimated to be valued US$ 7.79 billion. From 2024 to 2030, the global market for transdermal skin patches is anticipated to expand at a CAGR of 3.48%.

An adhesive patch that has been medicated and applied to the skin to deliver a specified dosage of medication through the skin and into the bloodstream is called a transdermal patch. It delivers drugs in a non-invasive, painless manner with the advantage of a steady therapeutic dose over a set amount of time.

Market Challenges – Recalls of Transdermal Drug Delivery Systems

Throughout the projected period, the expansion of the transdermal skin patch market is anticipated to be hampered by drug failure and recalls of transdermal drug delivery systems. For example, in November 2021, the pharmaceutical company Teva Pharmaceutical Industries Ltd. declared that a single lot of transdermal clonidine patches had been recalled by the U.S. Food and Drug Administration (FDA) due to noncompliance with degradation/impurity standards.

Type – Market breakup from 4 viewpoints:

1.    Matrix

2.    Reservoir

3.    Drug-in-Adhesive

4.    Other Types

Application – Market breakup from 5 viewpoints:

1.    Pain Relief

2.    Smoking Reduction and Cessation Aid

3.    Overactive Bladder

4.    Hormonal Therapy

5.    Others

Distribution Channel – Market breakup from 3 viewpoints:

1.    Hospital Pharmacies

2.    Retail Pharmacies

3.    Online Pharmacies

Market Opportunities – Development of Smart and Interactive Transdermal Patches

The creation of intelligent and interactive transdermal patches has encouraging prospects for business expansion for transdermal skin patches worldwide. By combining cutting-edge technologies that enable real-time patient monitoring and feedback, these next-generation patches go beyond conventional transdermal drug administration. Miniaturized electronics, sensors, and communication features are integrated into smart transdermal patches. This enables them to gather a variety of biomarker data from the skin in a passive manner, including temperature, hydration levels, glucose concentrations, and more. Wireless transmission of the gathered data to medical professionals or caregivers can offer real-time medical insights. An additional degree of round-the-clock monitoring can assist patients with chronic illnesses like diabetes and heart ailments manage their care more proactively and avoid serious complications.

How does Transdermal Drug Delivery Work?

For a medication to be applied topically, it needs specific properties. Its constituent components need to have a low molecular weight and be lipophilic, or able to travel in lipids. The molecules from the patch must pass through a few layers of skin in order for the medications to enter the bloodstream. The stratum corneum, the outer layer of dead, flattened skin cells that aid in preventing poisons and pathogens from entering the body, must first be crossed by the molecules. After passing through the dermis and epidermis, the molecules are eventually absorbed into peripheral capillary capillaries and dispersed throughout the remainder of the body.

Country –This report covers the 17 countries

North America

• United States
• Canada
• Mexico
• Brazil

Europe

• United Kingdom
• Germany
• France
• Italy
• Spain
• Netherlands

      Asia Pacific

• China
• Japan
• India
• South Korea
• Australia

      Middle East & Africa

• United Arab Emirates
• South Africa

Regional Insights

Due to its sophisticated healthcare system and legal frameworks that make it easier to develop and approve cutting-edge transdermal patch technologies, North America held a dominant position in the market in 2023. Furthermore, the need for simple and efficient treatment solutions like transdermal patches is fueled by the increasing prevalence of chronic diseases in North America, including diabetes, cardiovascular problems, and chronic pain issues. According to the CDC, smoking causes more than 480,000 deaths and is the primary preventable cause of disease, disability, and death in the United States. Over 16 million Americans and 28.3 million adults in the United States suffered from smoking-related ailments in 2021 as a result of the 11.5% of adults in the country who were 18 or older who were smokers.

Related Report:

Global Intrauterine Devices Market

Salivary Gland Infection Market

Europe Retinal Surgery Devices Market

All companies have been covered from 3 viewpoints:

•    Overview
•    Recent Developments
•    Revenue 

Company Analysis:

1.    Teva Pharmaceutical Industries Ltd,
2.    3M Company
3.    Nitto Denko Corporation
4.    Johnson & Johnson
5.    Luye Pharma Group
6.    Bayer
7.    Novartis AG
8.    Beiersdorf AG
9.    Viatris Inc.,
10.    Abbott Laboratories

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 9000 syndicated reports and worked on more than 750 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.